Tissue-resident memory T cells and lung immunopathology
被引:27
作者:
Cheon, In Su
论文数: 0引用数: 0
h-index: 0
机构:
Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA
Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USAUniv Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA
Cheon, In Su
[1
,2
]
Son, Young Min
论文数: 0引用数: 0
h-index: 0
机构:
Chung Ang Univ, Dept Syst Biotechnol, Anseong, South KoreaUniv Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA
Son, Young Min
[3
]
Sun, Jie
论文数: 0引用数: 0
h-index: 0
机构:
Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA
Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USAUniv Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA
Sun, Jie
[1
,2
]
机构:
[1] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA
[2] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA
[3] Chung Ang Univ, Dept Syst Biotechnol, Anseong, South Korea
Rapid reaction to microbes invading mucosal tissues is key to protect the host against disease. Respiratory tissue-resident memory T (T-RM) cells provide superior immunity against pathogen infection and/or re-infection, due to their presence at the site of pathogen entry. However, there has been emerging evidence that exuberant T-RM-cell responses contribute to the development of various chronic respiratory conditions including pulmonary sequelae post-acute viral infections. In this review, we have described the characteristics of respiratory T-RM cells and processes underlying their development and maintenance. We have reviewed T-RM-cell protective functions against various respiratory pathogens as well as their pathological activities in chronic lung conditions including post-viral pulmonary sequelae. Furthermore, we have discussed potential mechanisms regulating the pathological activity of T-RM cells and proposed therapeutic strategies to alleviate T-RM-cell-mediated lung immunopathology. We hope that this review provides insights toward the development of future vaccines or interventions that can harness the superior protective abilities of T-RM cells, while minimizing the potential for immunopathology, a particularly important topic in the era of coronavirus disease 2019 (COVID-19) pandemic.